John P.

Butler, President and CEO of Akebia Therapeutics, Takes Helm as New

Chair of Nation’s Largest Kidney Coalition

Butler will focus on supporting innovation to improve patient-centric care for individuals living with
kidney disease, kidney failure and transplants.

Washington, DC, January 21, 2020 --(PR.com)-- Kidney Care Partners (KCP) - the nation's leading
kidney care coalition composed of patients, caregivers, providers, researchers and manufacturers - is
pleased to announce John P. Butler as its new chair. Butler, a long-standing member and officer of KCP,
succeeds outgoing chairman Allen R. Nissenson, MD, FACP, Chief Medical Officer for DaVita Kidney
Care and emeritus professor of medicine at the David Geffen School of Medicine at UCLA, who served
from 2018 to the end of 2019. Butler was elected among his peers to serve a two-year term from
2020-2022.

Butler is the President and Chief Executive Officer of Akebia Therapeutics, a biopharmaceutical
company focused on the development and commercialization of therapeutics for people living with
kidney disease. Butler has formerly served as a Chairman of the Board of Trustees of the American
Kidney Fund, one of the nation's leading kidney disease nonprofit organizations.

“Kidney Care Partners advocates for people living with kidney disease, and champions programs and
policies to increase awareness, ensure access to care and empower patient-centered decision making,”
said John P. Butler. “It is a great privilege to be elected among my peers to serve in this leadership role
and I look forward to advancing initiatives that promote and support innovation to meet the needs of a
large under-served population.”

Today, there are an estimated 37 million American adults who are living with chronic kidney disease
(CKD), which if untreated, can ultimately progress to kidney failure - an irreversible condition that is
fatal without a kidney transplant or life-sustaining dialysis treatments. Each year in the United States,
more than 124,000 Americans are diagnosed with kidney failure. Currently, more than 700,000
Americans suffer from end-stage renal disease (ESRD) and over 500,000 are on dialysis.

“This is an opportune time to act on alignment among dedicated, bipartisan members of Congress, the
Administration, and the broader kidney community to advance innovative renal therapeutics and
technologies that have the potential to dramatically improve health outcomes,” Butler added. “As the
largest kidney coalition, KCP can lead a confluence of gifted minds and focused resources to take the
standard of kidney care to a higher level.”

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Kidney Care Partners
Sarah Ann Rhoades
703-548-0019
Contact via Email
http://www.kidneycarepartners.org/

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/803878

Page 2/2
PR.com Press Release Distribution Terms of Use